カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界のHPV四価ワクチン市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global HPV Quadrivalent Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7876）・商品コード：GIR23SM7876
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のHPV四価ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のHPV四価ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- HPV四価ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

HPV四価ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・HPV6型、HPV11型、HPV16型、HPV18型

用途別セグメント
・がん予防、疾病予防

主要な市場プレーヤー
・Merck、GlaxoSmithKline、Sanofi、Serum Institute of India、CSL (Commonwealth Serum Laboratories)

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、HPV四価ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なHPV四価ワクチンメーカーの企業概要、2019年～2022年までのHPV四価ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なHPV四価ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別HPV四価ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのHPV四価ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのHPV四価ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびHPV四価ワクチンの産業チェーンを掲載しています。
・第14、15章では、HPV四価ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– HPV四価ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：HPV6型、HPV11型、HPV16型、HPV18型
– 用途別分析（2018年vs2022年vs2029年）：がん予防、疾病予防
– 世界のHPV四価ワクチン市場規模・予測
– 世界のHPV四価ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Merck、GlaxoSmithKline、Sanofi、Serum Institute of India、CSL (Commonwealth Serum Laboratories)
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：HPV6型、HPV11型、HPV16型、HPV18型
・用途別分析2018年-2029年：がん予防、疾病予防
・HPV四価ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・HPV四価ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・HPV四価ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・HPV四価ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・HPV四価ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of HPV Quadrivalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HPV Quadrivalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 HPV6 Type
1.3.3 HPV11 Type
1.3.4 HPV16 Type
1.3.5 HPV18 Type
1.4 Market Analysis by Application
1.4.1 Overview: Global HPV Quadrivalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer Prevention
1.4.3 Disease Prevention
1.5 Global HPV Quadrivalent Vaccine Market Size & Forecast
1.5.1 Global HPV Quadrivalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global HPV Quadrivalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global HPV Quadrivalent Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck HPV Quadrivalent Vaccine Product and Services
2.1.4 Merck HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline HPV Quadrivalent Vaccine Product and Services
2.2.4 GlaxoSmithKline HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi HPV Quadrivalent Vaccine Product and Services
2.3.4 Sanofi HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sanofi Recent Developments/Updates
2.4 Serum Institute of India
2.4.1 Serum Institute of India Details
2.4.2 Serum Institute of India Major Business
2.4.3 Serum Institute of India HPV Quadrivalent Vaccine Product and Services
2.4.4 Serum Institute of India HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Serum Institute of India Recent Developments/Updates
2.5 CSL (Commonwealth Serum Laboratories)
2.5.1 CSL (Commonwealth Serum Laboratories) Details
2.5.2 CSL (Commonwealth Serum Laboratories) Major Business
2.5.3 CSL (Commonwealth Serum Laboratories) HPV Quadrivalent Vaccine Product and Services
2.5.4 CSL (Commonwealth Serum Laboratories) HPV Quadrivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CSL (Commonwealth Serum Laboratories) Recent Developments/Updates
3 Competitive Environment: HPV Quadrivalent Vaccine by Manufacturer
3.1 Global HPV Quadrivalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global HPV Quadrivalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global HPV Quadrivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of HPV Quadrivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 HPV Quadrivalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 HPV Quadrivalent Vaccine Manufacturer Market Share in 2022
3.5 HPV Quadrivalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 HPV Quadrivalent Vaccine Market: Region Footprint
3.5.2 HPV Quadrivalent Vaccine Market: Company Product Type Footprint
3.5.3 HPV Quadrivalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global HPV Quadrivalent Vaccine Market Size by Region
4.1.1 Global HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global HPV Quadrivalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global HPV Quadrivalent Vaccine Average Price by Region (2018-2029)
4.2 North America HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.3 Europe HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.5 South America HPV Quadrivalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa HPV Quadrivalent Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global HPV Quadrivalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global HPV Quadrivalent Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global HPV Quadrivalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global HPV Quadrivalent Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America HPV Quadrivalent Vaccine Market Size by Country
7.3.1 North America HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe HPV Quadrivalent Vaccine Market Size by Country
8.3.1 Europe HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific HPV Quadrivalent Vaccine Market Size by Region
9.3.1 Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific HPV Quadrivalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America HPV Quadrivalent Vaccine Market Size by Country
10.3.1 South America HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa HPV Quadrivalent Vaccine Market Size by Country
11.3.1 Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa HPV Quadrivalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 HPV Quadrivalent Vaccine Market Drivers
12.2 HPV Quadrivalent Vaccine Market Restraints
12.3 HPV Quadrivalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of HPV Quadrivalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of HPV Quadrivalent Vaccine
13.3 HPV Quadrivalent Vaccine Production Process
13.4 HPV Quadrivalent Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HPV Quadrivalent Vaccine Typical Distributors
14.3 HPV Quadrivalent Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global HPV Quadrivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global HPV Quadrivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck HPV Quadrivalent Vaccine Product and Services
Table 6. Merck HPV Quadrivalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Major Business
Table 10. GlaxoSmithKline HPV Quadrivalent Vaccine Product and Services
Table 11. GlaxoSmithKline HPV Quadrivalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GlaxoSmithKline Recent Developments/Updates
Table 13. Sanofi Basic Information, Manufacturing Base and Competitors
Table 14. Sanofi Major Business
Table 15. Sanofi HPV Quadrivalent Vaccine Product and Services
Table 16. Sanofi HPV Quadrivalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Sanofi Recent Developments/Updates
Table 18. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 19. Serum Institute of India Major Business
Table 20. Serum Institute of India HPV Quadrivalent Vaccine Product and Services
Table 21. Serum Institute of India HPV Quadrivalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Serum Institute of India Recent Developments/Updates
Table 23. CSL (Commonwealth Serum Laboratories) Basic Information, Manufacturing Base and Competitors
Table 24. CSL (Commonwealth Serum Laboratories) Major Business
Table 25. CSL (Commonwealth Serum Laboratories) HPV Quadrivalent Vaccine Product and Services
Table 26. CSL (Commonwealth Serum Laboratories) HPV Quadrivalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CSL (Commonwealth Serum Laboratories) Recent Developments/Updates
Table 28. Global HPV Quadrivalent Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 29. Global HPV Quadrivalent Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 30. Global HPV Quadrivalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 31. Market Position of Manufacturers in HPV Quadrivalent Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 32. Head Office and HPV Quadrivalent Vaccine Production Site of Key Manufacturer
Table 33. HPV Quadrivalent Vaccine Market: Company Product Type Footprint
Table 34. HPV Quadrivalent Vaccine Market: Company Product Application Footprint
Table 35. HPV Quadrivalent Vaccine New Market Entrants and Barriers to Market Entry
Table 36. HPV Quadrivalent Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 38. Global HPV Quadrivalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 39. Global HPV Quadrivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 40. Global HPV Quadrivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 41. Global HPV Quadrivalent Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 42. Global HPV Quadrivalent Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 43. Global HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 44. Global HPV Quadrivalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 45. Global HPV Quadrivalent Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 46. Global HPV Quadrivalent Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 47. Global HPV Quadrivalent Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 48. Global HPV Quadrivalent Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 49. Global HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 50. Global HPV Quadrivalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 51. Global HPV Quadrivalent Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 52. Global HPV Quadrivalent Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 53. Global HPV Quadrivalent Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 54. Global HPV Quadrivalent Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 55. North America HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 56. North America HPV Quadrivalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 57. North America HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 58. North America HPV Quadrivalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 59. North America HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 60. North America HPV Quadrivalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 61. North America HPV Quadrivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 62. North America HPV Quadrivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 63. Europe HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Europe HPV Quadrivalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Europe HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 66. Europe HPV Quadrivalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 67. Europe HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 68. Europe HPV Quadrivalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 69. Europe HPV Quadrivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe HPV Quadrivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 72. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 73. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 74. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 75. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 76. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 77. Asia-Pacific HPV Quadrivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 78. Asia-Pacific HPV Quadrivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 79. South America HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 80. South America HPV Quadrivalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 81. South America HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 82. South America HPV Quadrivalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 83. South America HPV Quadrivalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 84. South America HPV Quadrivalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 85. South America HPV Quadrivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 86. South America HPV Quadrivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 87. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 88. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 89. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 92. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 93. Middle East & Africa HPV Quadrivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 94. Middle East & Africa HPV Quadrivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 95. HPV Quadrivalent Vaccine Raw Material
Table 96. Key Manufacturers of HPV Quadrivalent Vaccine Raw Materials
Table 97. HPV Quadrivalent Vaccine Typical Distributors
Table 98. HPV Quadrivalent Vaccine Typical Customers
List of Figures
Figure 1. HPV Quadrivalent Vaccine Picture
Figure 2. Global HPV Quadrivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global HPV Quadrivalent Vaccine Consumption Value Market Share by Type in 2022
Figure 4. HPV6 Type Examples
Figure 5. HPV11 Type Examples
Figure 6. HPV16 Type Examples
Figure 7. HPV18 Type Examples
Figure 8. Global HPV Quadrivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global HPV Quadrivalent Vaccine Consumption Value Market Share by Application in 2022
Figure 10. Cancer Prevention Examples
Figure 11. Disease Prevention Examples
Figure 12. Global HPV Quadrivalent Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global HPV Quadrivalent Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global HPV Quadrivalent Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 15. Global HPV Quadrivalent Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global HPV Quadrivalent Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global HPV Quadrivalent Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of HPV Quadrivalent Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 HPV Quadrivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 HPV Quadrivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global HPV Quadrivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global HPV Quadrivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America HPV Quadrivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe HPV Quadrivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific HPV Quadrivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America HPV Quadrivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa HPV Quadrivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global HPV Quadrivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global HPV Quadrivalent Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global HPV Quadrivalent Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global HPV Quadrivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global HPV Quadrivalent Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global HPV Quadrivalent Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America HPV Quadrivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America HPV Quadrivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America HPV Quadrivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America HPV Quadrivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe HPV Quadrivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe HPV Quadrivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe HPV Quadrivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe HPV Quadrivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific HPV Quadrivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific HPV Quadrivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 54. China HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America HPV Quadrivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America HPV Quadrivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America HPV Quadrivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America HPV Quadrivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa HPV Quadrivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa HPV Quadrivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa HPV Quadrivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. HPV Quadrivalent Vaccine Market Drivers
Figure 75. HPV Quadrivalent Vaccine Market Restraints
Figure 76. HPV Quadrivalent Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of HPV Quadrivalent Vaccine in 2022
Figure 79. Manufacturing Process Analysis of HPV Quadrivalent Vaccine
Figure 80. HPV Quadrivalent Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source


★調査レポート[世界のHPV四価ワクチン市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7876)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のHPV四価ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の経鼻ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の人工血清市場2023年：企業・地域・タイプ・用途別分析
  • 世界の組換えヒト血清アルブミン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のmRNA新型コロナウイルスワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口コレラワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の経口狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のJE不活化ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のヒト血清アルブミン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の豚用弱毒生ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の新型コロナウイルス感染用症経口ワクチン市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆